ADmark Phospho-Tau/Total-TA TAUCSF

Synonyms
Allscripts (AEHR) Order Name	ADmark Phospho-Tau/Total-TA
Sunrise Clinical Manager (SCM) Order Name	ADmark Phospho-Tau/Total-TA
EPIC Order Name	CSF, ADmark Phospho-Tau/Total-Tau/A Beta42, Analysis and Interpretation (Symptomatic)
Clinical Info	ADmark® Alzheimer's Eval, CSF (FDA Approved) - Elecsys Beta Amyloid (1 42) CSF II, Phospho-Tau (181P) CSF and Elecsys Total Tau CSF are in vitro electrochemiluminescence immunoassays for the measurement of the Beta Amyloid (1 42) (Abeta42), PTau (181P) and Total Tau (tTau) protein concentration in cerebrospinal fluid (CSF) from adult patients aged 55 years and older being evaluated for Alzheimer's disease (AD) and other causes of cognitive impairment to generate a tTau/Abeta42 and pTau-181/Abeta42 ratios and values.
Specimen Type	CSF
Specimen Volume	1 mL CSF ( 0.7 mL min)
Container	CSF Tube
Collection Instructions	Container/Tube: 1 mL CSF (0.7 mL minimum) collected in a low-binding polypropylene tube (63.614.625 Sarstedt; Quest supply order number: ST100). Specimen: 1 mL CSF ( 0.7 mL min) Reject Criteria CSF samples that arrive in non-polypropylene tubes • CSF specimens with Gross Hemolysis
Transport Instructions	Refrigerated
Specimen Stability	Room temperature: 5 days Refrigerated: 14 days Frozen: 56 days
Methodology	Electrochemiluminescence (ECLIA)
Days Performed	TAT: 3-5 Days
Performing Laboratory	Quest Diagnostic Nichols Institute Chantilly VA to Quest Diagnostics Nichols Institute-San Juan Capistrano, CA
CPT	84393 82234 84394
PDM	2159034
Result Interpretation See report
Forms